key: cord-0830486-al2gimy9
authors: Gresham, Louise M.; Marzario, Barbara; Dutz, Jan; Kirchhof, Mark G.
title: Response to Comment on “An Evidence-Based Guide to SARS-Cov-1 2 Vaccination of Patients on Immunotherapies in Dermatology.”
date: 2021-04-17
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2021.04.026
sha: 0b84674b473bb98d5badf5d414bc3714366dc286
doc_id: 830486
cord_uid: al2gimy9

nan

Patients on Immunotherapies in Dermatology." 2 3

Louise M. Gresham We appreciate the authors' attention to detail in noting that in the study by Cho et 

Robust memory responses against influenza 70 vaccination in pemphigus patients previously treated with rituximab

Effect of ocrelizumab on vaccine responses in 73 patients with multiple sclerosis: The VELOCE study

Toward a COVID-19 vaccine strategy for 76 patients with pemphigus on rituximab

Demonstration of rebound phenomenon 78 following abrupt withdrawal of the JAK1 inhibitor oclacitinib

CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients